Your browser doesn't support javascript.
loading
Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.
Zhao, J; van Mierlo, K M C; Gómez-Ramírez, J; Kim, H; Pilgrim, C H C; Pessaux, P; Rensen, S S; van der Stok, E P; Schaap, F G; Soubrane, O; Takamoto, T; Viganò, L; Winkens, B; Dejong, C H C; Olde Damink, S W M.
Afiliación
  • Zhao J; Department of Surgery, Maastricht University Medical Centre and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • van Mierlo KMC; Department of Surgery, Maastricht University Medical Centre and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • Gómez-Ramírez J; Hepatopancreaticobiliary Surgery Unit, Department of Surgery, Hospital Universitario de la Princesa, Madrid, Spain.
  • Kim H; Department of Pathology, Seoul National University Bundang Hospital, Seoul National College of Medicine, Seongnam, Korea.
  • Pilgrim CHC; Hepatopancreaticobiliary Service, Upper Gastrointestinal Surgery, The Alfred Hospital, and Division of Cancer Surgery, Peter MacCallum Cancer Centre, Department of Surgery, University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Pessaux P; Digestive Surgery and Transplantation, Hôpital de Hautepierre, University Hospital of Strasbourg, Strasbourg, France.
  • Rensen SS; Department of Surgery, Maastricht University Medical Centre and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • van der Stok EP; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Schaap FG; Department of Surgery, Maastricht University Medical Centre and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • Soubrane O; Department of Hepatobiliary Surgery and Liver Transplant, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris, Université Denis Diderot, Paris, France.
  • Takamoto T; Department of Hepatopancreaticobiliary Surgery, Japanese Red Cross Medical Centre, Tokyo, Japan.
  • Viganò L; Division of Hepatobiliary and General Surgery, Humanitas Clinical and Research Centre, Humanitas University, Rozzano, Italy.
  • Winkens B; Department of Methodology and Statistics, Maastricht University Medical Centre, and CAPHRI School for Public Health and Primary Care, Maastricht, The Netherlands.
  • Dejong CHC; Department of Surgery, Maastricht University Medical Centre and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • Olde Damink SWM; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Br J Surg ; 104(8): 990-1002, 2017 Jul.
Article en En | MEDLINE | ID: mdl-28542731
ABSTRACT

BACKGROUND:

The impact of chemotherapy-associated liver injury (CALI) on postoperative outcome in patients undergoing partial hepatectomy for colorectal liver metastases (CRLM) remains controversial. The objective of this study was to clarify the effect of CALI (sinusoidal dilatation (SD), steatosis and steatohepatitis) on postoperative morbidity and mortality by investigating a large data set from multiple international centres.

METHODS:

PubMed and Embase were searched for studies published between 1 January 2004 and 31 December 2013 with keywords 'chemotherapy', 'liver resection', 'outcome' and 'colorectal metastases' to identify potential collaborating centres. Univariable and multivariable analyses were performed using binary logistic regression models, with results presented as odds ratios (ORs) with 95 per cent confidence intervals.

RESULTS:

A consolidated database comprising 788 patients who underwent hepatectomy for CRLM in eight centres was obtained. In multivariable analyses, severe SD was associated with increased major morbidity (Dindo-Clavien grade III-V; OR 1·73, 95 per cent c.i. 1·02 to 2·95; P = 0·043). Severe steatosis was associated with decreased liver surgery-specific complications (OR 0·52, 95 per cent c.i. 0·27 to 1·00; P = 0·049), whereas steatohepatitis was linked to an increase in these complications (OR 2·08, 1·18 to 3·66; P = 0·012). Subgroup analysis showed that lobular inflammation was the sole component associated with increased overall morbidity (OR 2·22, 1·48 to 3·34; P = 0·001) and liver surgery-specific complications (OR 3·35, 2·11 to 5·32; P < 0·001). Finally, oxaliplatin treatment was linked to severe SD (OR 2·74, 1·67 to 4·49; P < 0·001).

CONCLUSION:

An increase in postoperative major morbidity and liver surgery-specific complications was observed after partial hepatectomy in patients with severe SD and steatohepatitis. Postoperative liver failure occurred more often in patients with severe SD.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Enfermedad Hepática Inducida por Sustancias y Drogas / Hepatectomía / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Surg Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Enfermedad Hepática Inducida por Sustancias y Drogas / Hepatectomía / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Surg Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos